7-(3-chlorophenyl)-4-[4-(2,5-dimethylphenyl)sulfonylpiperazin-1-yl]-5-phenylpyrrolo[2,3-d]pyrimidine
C30H28ClN5O2S — CID 171692056
Data last refreshed: (MolForge compound catalog, from PubChem)
About 7-(3-chlorophenyl)-4-[4-(2,5-dimethylphenyl)sulfonylpiperazin-1-yl]-5-phenylpyrrolo[2,3-d]pyrimidine
7-(3-chlorophenyl)-4-[4-(2,5-dimethylphenyl)sulfonylpiperazin-1-yl]-5-phenylpyrrolo[2,3-d]pyrimidine (PubChem CID 171692056) has the molecular formula C30H28ClN5O2S and a molecular weight of 558.11 g/mol. Its IUPAC name is 7-(3-chlorophenyl)-4-[4-(2,5-dimethylphenyl)sulfonylpiperazin-1-yl]-5-phenylpyrrolo[2,3-d]pyrimidine.
Molecular Properties
| Compound Name | 7-(3-chlorophenyl)-4-[4-(2,5-dimethylphenyl)sulfonylpiperazin-1-yl]-5-phenylpyrrolo[2,3-d]pyrimidine |
|---|---|
| PubChem CID | 171692056 |
| Molecular Formula | C30H28ClN5O2S |
| Molecular Weight | 558.11 g/mol |
| Exact Mass | 557.17 |
| IUPAC Name | 7-(3-chlorophenyl)-4-[4-(2,5-dimethylphenyl)sulfonylpiperazin-1-yl]-5-phenylpyrrolo[2,3-d]pyrimidine |
| SMILES | Cc1ccc(C)c(S(=O)(=O)N2CCN(c3ncnc4c3c(-c3ccccc3)cn4-c3cccc(Cl)c3)CC2)c1 |
| InChI | InChI=1S/C30H28ClN5O2S/c1-21-11-12-22(2)27(17-21)39(37,38)35-15-13-34(14-16-35)29-28-26(23-7-4-3-5-8-23)19-36(30(28)33-20-32-29)25-10-6-9-24(31)18-25/h3-12,17-20H,13-16H2,1-2H3 |
| InChIKey | LAZXOAPXMMJFAH-UHFFFAOYSA-N |
| XLogP | 5.87 |
| TPSA | 71.33 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 558.11 |
| LogP ≤ 5 | 5.87 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171692056 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.